Newsmeme!
Discover News you didn't know existed
NicOx S.A. today announced it has signed an agreement with DSM for the commercial manufacture and supply of naproxcinod drug substance . Naproxcinod is NicOx' lead investigational product and the first compound in the Cyclooxygenase-Inhibiting Nitric Oxide-Donating class of anti-inflammatory agents, which recently achieved positive results in the third pivotal phase 3 study in osteoarthritis ...
No tags found at this time. Be the first to tag this news item, learn more.
NicOx signs agreement with DSM for the commercial manufacture of ... - Earthtimes
NicOx S.A. (NYSE Euronext Paris: COX) today announced it has signed an agreement with DSM for the commercial manufacture and supply of naproxcinod drug substance (or API, active pharmaceutical ingredient). Naproxcinod is NicOx' lead investigational ...
NicOx Signs Agreement With DSM for the Commercial Manufacture of ... - PR Newswire
SOPHIA ANTIPOLIS, France, December 2 /PRNewswire/ -- NicOx S.A. (NYSE: COX) (Euronext: COX) (Paris: COX) today announced it has signed an agreement with DSM for the commercial manufacture and supply of naproxcinod drug substance (or API, active ...
None found at this time.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |